Adverse events28

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

21 to 28 of 28

Type	Event	Organ system	Group	Affected	At risk	Events
serious	Back Pain	Musculoskeletal and connective tissue disorders	Verinurad 9 mg+Febuxostat 80 mg	1	32	1
serious	Back Pain	Musculoskeletal and connective tissue disorders	Placebo	0	28	0
serious	Acute Kidney Injury	Renal and urinary disorders	Verinurad 9 mg+Febuxostat 80 mg	1	32	1
serious	Acute Kidney Injury	Renal and urinary disorders	Placebo	0	28	0
serious	Dyspnoea	Respiratory, thoracic and mediastinal disorders	Verinurad 9 mg+Febuxostat 80 mg	1	32	2
serious	Dyspnoea	Respiratory, thoracic and mediastinal disorders	Placebo	0	28	0
serious	Wound Drainage	Surgical and medical procedures	Verinurad 9 mg+Febuxostat 80 mg	0	32	0
serious	Wound Drainage	Surgical and medical procedures	Placebo	1	28	1

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03118739/events?page=2